Skip navigation
Browsing by Author Horvath, L.
Showing results 1 to 1 of 1
| Preview | Issue Date | Title / Name | Author(s) |
| Jul-2020 | Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors | Desai, J.; Gan, H.; Barrow, C.; Jameson, M.; Atkinson, V.; Haydon, A.; Millward, M.; Begbie, S.; Brown, M.; Markman, B.; Patterson, W.; Hill, A.; Horvath, L.; Nagrial, A.; Richardson, G.; Jackson, C.; Friedlander, M.; Parente, P,; Tran, B.; Wang, L.; Chen, Y.; Tang, Z.; Huang, W.; Wu, J.; Zeng, D.; Luo, L.; Solomon, B.; Begbie, Stephen | |
